Accelerating Hope for Children

I-ACT for Children is a newly formed nonprofit that will work to assure that studies are designed to generate sufficient data to allow safe and effective use of new medications and devices in children. A key factor in making this a reality is to optimize and accelerate biomedical innovation using child-centered clinical trial networks and collaboration with like-minded institutions, trial sponsors and other stakeholders.

Dedicated, science-driven expertise is critical to developing safe, effective and properly formulated therapies for children. I-ACT for Children will play a pivotal role as an independent, child-centered catalyst that will help us all accelerate the availability of scientific data needed to inform the safe and effective use of medicines and devices for children globally.

Our patients are often best served when we partner with external independent experts, and by fostering these important collaborations, we facilitate innovative solutions that enhance the lives of children worldwide.

J&J co-led the Pediatric Trials Consortium that helped C-Path shape and support the establishment of the independent, non-profit Institute for Advanced Clinical Trials for Children (I-ACT for Children). I-ACT for Children aims to serve the needs of children by asking the right scientific questions, and providing the right data and evidence necessary for treating pediatric patients with confidence.

Read more. Accelerating Hope for Children